[HTML][HTML] Clinical diagnostic utility of transcranial magnetic stimulation in neurological disorders. Updated report of an IFCN committee

S Vucic, KHS Chen, MC Kiernan, M Hallett… - Clinical …, 2023 - Elsevier
The review provides a comprehensive update (previous report: Chen R, Cros D, Curra A, Di
Lazzaro V, Lefaucheur JP, Magistris MR, et al. The clinical diagnostic utility of transcranial …

Diagnostic contribution and therapeutic perspectives of transcranial magnetic stimulation in dementia

V Di Lazzaro, R Bella, A Benussi, M Bologna… - Clinical …, 2021 - Elsevier
Transcranial magnetic stimulation (TMS) is a powerful tool to probe in vivo brain circuits, as it
allows to assess several cortical properties such as excitability, plasticity and connectivity in …

[HTML][HTML] Parkinson's disease and its management: part 1: disease entity, risk factors, pathophysiology, clinical presentation, and diagnosis

G DeMaagd, A Philip - Pharmacy and therapeutics, 2015 - ncbi.nlm.nih.gov
Parkinson’s Disease and Its Management - PMC Back to Top Skip to main content NIH NLM
Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Search …

Patient-specific models link neurotransmitter receptor mechanisms with motor and visuospatial axes of Parkinson's disease

AF Khan, Q Adewale, SJ Lin, TR Baumeister… - Nature …, 2023 - nature.com
Parkinson's disease involves multiple neurotransmitter systems beyond the classical
dopaminergic circuit, but their influence on structural and functional alterations is not well …

[HTML][HTML] Clinical neurophysiology of Parkinson's disease and parkinsonism

R Chen, A Berardelli, A Bhattacharya… - Clinical neurophysiology …, 2022 - Elsevier
This review is part of the series on the clinical neurophysiology of movement disorders. It
focuses on Parkinson's disease and parkinsonism. The topics covered include the …

[HTML][HTML] Non-invasive brain stimulation for Parkinson's disease: Clinical evidence, latest concepts and future goals: A systematic review

J Madrid, DH Benninger - Journal of Neuroscience Methods, 2021 - Elsevier
Parkinson's disease (PD) is becoming a major public-health issue in an aging population.
Available approaches to treat advanced PD still have limitations; new therapies are needed …

Cortical disinhibition in Parkinson's disease

C Ammann, M Dileone, C Pagge, V Catanzaro… - Brain, 2020 - academic.oup.com
In Parkinson's disease, striatal dopamine depletion produces profound alterations in the
neural activity of the cortico-basal ganglia motor loop, leading to dysfunctional motor output …

[HTML][HTML] Dopaminergic modulation of primary motor cortex: From cellular and synaptic mechanisms underlying motor learning to cognitive symptoms in Parkinson's …

J Cousineau, V Plateau, J Baufreton… - Neurobiology of …, 2022 - Elsevier
The primary motor cortex (M1) is crucial for movement execution, especially dexterous ones,
but also for cognitive functions like motor learning. The acquisition of motor skills to execute …

Increased motor cortical facilitation and decreased inhibition in Parkinson disease

Z Ni, N Bahl, CA Gunraj, F Mazzella, R Chen - Neurology, 2013 - AAN Enterprises
Objective: To identify the changes in motor cortical facilitatory and inhibitory circuits in
Parkinson disease (PD) by detailed studies of their time courses and interactions. Methods …

Invasive and noninvasive brain stimulation in Parkinson's disease: clinical effects and future perspectives

KHS Chen, R Chen - Clinical Pharmacology & Therapeutics, 2019 - Wiley Online Library
In this review, we discuss the clinical and electrophysiological effects and the future
directions of invasive and noninvasive brain stimulations in Parkinson's disease (PD). Deep …